Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition
Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal ...
Thursday, May 1, 2025
Tag: Novartis
Novartis Nabs First FDA Nod in Rare Kidney Disease, But Apellis Pharma Is on Its Heels
An ultra-rare kidney disease that can become life-threatening now has its first FDA-approved therapy. The affirmative regulatory decision is the ...
Biocon inks pact with Sandoz for sale of 2 biosimilar products in Australia
Biocon Biologics on Friday said it has inked a five-year pact with pharmaceutical company Sandoz AG regarding the sale ...
Alphabet’s Isomorphic labs to collaborate with Novartis, Lilly on AI-driven drug discovery
Bloomberg—Isomorphic Labs, a subsidiary of Alphabet Inc., said it entered into strategic research collaboration agreements with Novartis AG and Eli ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.